Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Sarkozi, R; Perco, P; Hochegger, K; Enrich, J; Wiesinger, M; Pirklbauer, M; Eder, S; Rudnicki, M; Rosenkranz, AR; Mayer, B; Mayer, G; Schramek, H.
Bortezomib-induced survival signals and genes in human proximal tubular cells.
J Pharmacol Exp Ther. 2008; 327(3):645-656
Doi: 10.1124/jpet.108.142604
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Eller Kathrin
- Rosenkranz Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Bortezomib has been introduced recently in the therapy of multiple myeloma (MM), a disease that is frequently associated with progressive renal failure. Because bortezomib-based therapy has been reported to lead to a rapid recovery of kidney function in patients with MM, we decided to study its direct effects in proximal tubular epithelial cells (PTCs) compared with glomerular mesangial cells (GMCs). After 24 h of stimulation, 50 nM bortezomib led to a 6.37-fold induction of apoptosis and markedly activated caspase-9 and -3 in GMCs but not in PTCs. In PTCs but not in GMCs, bortezomib led to a strong time-dependent degradation of IkappaB-alpha and to a long-lasting phosphorylation of both NF-kappaBp65 and extracellular signal-regulated kinase 1/2. Microarray analysis in bortezomib-treated PTCs revealed a time-dependent predominance of antiapoptotic genes compared with proapoptotic genes. Bortezomib (50 nM) induced heat shock protein (Hsp) 70 mRNA and protein levels in PTCs, whereas basal and bortezomib-stimulated Hsp70 protein expression was much weaker in GMCs. Moreover, bortezomib induced Bcl-2-associated athanogene (BAG) 3 mRNA and protein expression but inhibited BAG5 mRNA levels in PTCs. These data suggest that the reduced susceptibility of PTCs to bortezomib-induced cell apoptosis is because of cell type-specific effects of this compound on apoptosis/survival genes and pathways. The concept of bortezomib representing a blocker of both NF-kappaB activation and cell survival should be carefully examined in particular renal cell types.
- Find related publications in this database (using NLM MeSH Indexing)
- Apoptosis - drug effects Apoptosis - genetics
- Boronic Acids - pharmacology
- Cell Survival - drug effects Cell Survival - genetics
- Gene Expression Regulation - drug effects
- HSP70 Heat-Shock Proteins - genetics
- Humans -
- I-kappa B Proteins - antagonists and inhibitors I-kappa B Proteins - metabolism
- Kidney Tubules, Proximal - cytology
- Mesangial Cells - cytology
- Mitogen-Activated Protein Kinase 3 - metabolism
- Pyrazines - pharmacology
- Signal Transduction - drug effects Signal Transduction - genetics
- Transcription Factor RelA - metabolism